Chester County News and Community Website
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported its second-quarter financial results and announced a series of significant regulatory, clinical, and corporate developments that strengthen its position in the …
NRx Pharmaceuticals Secures Expanded FDA Fast Track Designation and Strategic Investments Amid Growth Plans Read More WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) will release its second-quarter 2025 financial results after market close on Thursday, August 14, followed by a 4:30 p.m. ET conference call …
NRx Pharmaceuticals to Report Q2 2025 Results on August 14 Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has achieved a significant milestone in the development of its antidepressant drug, NRX-100 (Ketamine). On September 24, 2024, the company announced that the …
NRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100 Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently received attention in an article on Psychiatrist.com, which discussed the potential of its pipeline products, NRX-100 and NRX-101, in addressing bipolar depression …
NRx Pharmaceuticals’ Innovative Treatments for Depression Gain Spotlight Read More